https://www.nasdaq.com/press-release/avinger-announces-fda-clearance-of-pantheris-for-the-treatment-of-in-stent-restenosis
https://www.nasdaq.com/press-release/avinger-reports-third-quarter-2021-financial-results-2021-11-11
https://www.nasdaq.com/press-release/avinger-to-announce-third-quarter-results-on-november-11-2021-2021-10-29
https://www.nasdaq.com/press-release/ground-breaking-clinical-data-from-insight-trial-presented-at-viva-2021-10-07
https://www.nasdaq.com/press-release/avinger-to-present-at-the-h.c.-wainwright-23rd-annual-global-investment-conference
https://www.nasdaq.com/press-release/avinger-oct-guided-technologies-featured-at-amp-2021-2021-08-16
https://www.nasdaq.com/press-release/avinger-reports-second-quarter-2021-financial-results-2021-08-10
https://www.nasdaq.com/press-release/avinger-announces-510k-filing-for-new-lightbox-3-imaging-console-2021-08-09
https://www.nasdaq.com/press-release/avinger-to-announce-second-quarter-2021-results-on-august-10-2021-2021-07-27
https://www.nasdaq.com/press-release/avinger-announces-510k-filing-for-new-pantheris-in-stent-restenosis-indication-2021
https://www.nasdaq.com/press-release/avinger-announces-key-opinion-leader-presentations-at-vascular-conferences-in-germany
https://www.nasdaq.com/press-release/avinger-announces-presentations-by-key-opinion-leaders-at-new-cardiovascular-horizons
https://www.nasdaq.com/press-release/avinger-announces-issuance-and-allowance-of-seven-u.s.-patents-2021-05-25
https://www.nasdaq.com/press-release/avinger-to-present-at-the-oppenheimer-medtech-tools-diagnostics-summit-may-26-2021-05
https://www.nasdaq.com/press-release/avinger-reports-first-quarter-2021-financial-results-2021-05-13
https://www.nasdaq.com/press-release/avinger-to-announce-first-quarter-2021-results-on-may-6-2021-2021-04-26
https://www.nasdaq.com/press-release/new-publications-highlight-clinical-benefits-of-avinger-pad-therapies-2021-04-21
https://www.nasdaq.com/press-release/avinger-achieves-commercial-milestone-with-more-than-100-accounts-using-pantheris-sv
https://www.nasdaq.com/press-release/avinger-provides-update-on-tigereyetm-commercial-launch-2021-04-08
https://www.nasdaq.com/press-release/avinger-reports-fourth-quarter-2020-financial-results-2021-03-11
https://www.nasdaq.com/press-release/avinger-inc.-to-present-at-the-q1-virtual-investor-summit-2021-03-11
https://www.nasdaq.com/press-release/avinger-to-announce-fourth-quarter-full-year-2020-results-on-march-11-2021-2021-03-02
https://www.nasdaq.com/press-release/aegis-capital-corp.-acted-as-sole-bookrunner-on-a-%2414.4-million-bought-deal-offering
https://www.nasdaq.com/press-release/avinger-tigereye-cto-crossing-featured-in-live-case-at-linc-2021-2021-02-03
https://www.nasdaq.com/press-release/avinger-closes-%2414.4-million-bought-deal-offering-of-common-stock-2021-02-02
https://www.nasdaq.com/press-release/avinger-announces-%2414.4-million-bought-deal-offering-of-common-stock-2021-01-28
https://www.nasdaq.com/press-release/avinger-regains-compliance-with-nasdaq-listing-requirements-2021-01-27
https://www.nasdaq.com/press-release/avinger-improves-terms-of-existing-crg-loan-agreement-2021-01-26
https://www.nasdaq.com/press-release/avinger-expands-intellectual-property-portfolio-2021-01-19
https://www.nasdaq.com/press-release/avinger-initiates-full-commercial-launch-of-tigereyetm-image-guided-cto-crossing
https://www.nasdaq.com/press-release/avinger-to-participate-in-hc-wainwright-conference-2021-01-06
https://www.nasdaq.com/press-release/avinger-announces-annual-meeting-results-2020-12-23
https://www.nasdaq.com/press-release/avinger-adjourns-annual-meeting-of-stockholders-2020-12-11
https://www.nasdaq.com/press-release/avinger-expands-tigereyetm-limited-launch-2020-12-04
https://www.nasdaq.com/press-release/avinger-receives-nasdaq-extension-recommends-stockholders-vote-for-all-proxy
https://www.nasdaq.com/press-release/avinger-reports-third-quarter-2020-financial-results-2020-11-10
https://www.nasdaq.com/press-release/avinger-announces-commercial-launch-in-israel-2020-11-05
https://www.nasdaq.com/press-release/avinger-to-announce-third-quarter-2020-results-on-november-10-2020-2020-10-28
https://www.nasdaq.com/press-release/avinger-announces-first-us-cases-with-tigereyetm-image-guided-cto-crossing-catheter
https://www.nasdaq.com/press-release/avinger-receives-fda-clearance-of-ocelaris-next-generation-image-guided-cto-crossing
https://www.nasdaq.com/press-release/avinger-announces-exercise-and-closing-of-underwriters-over-allotment-2020-09-01
https://www.nasdaq.com/press-release/aegis-capital-corp.-acted-as-sole-bookrunner-on-a-%245.2-million-follow-on-offering-for
https://www.nasdaq.com/press-release/avinger-closes-%245.2-million-underwritten-public-offering-of-common-stock-2020-08-25
https://www.nasdaq.com/press-release/avinger-prices-%245.2-million-underwritten-public-offering-of-common-stock-2020-08-20
https://www.nasdaq.com/press-release/avinger-announces-exercise-and-closing-of-underwriters-over-allotment-2020-08-11
https://www.nasdaq.com/press-release/aegis-capital-corp.-acted-as-sole-bookrunner-on-a-%246000000-follow-on-offering-for-0
https://www.nasdaq.com/press-release/avinger-closes-%246-million-underwritten-public-offering-of-common-stock-2020-08-06
https://www.nasdaq.com/press-release/avinger-prices-%246-million-underwritten-public-offering-of-common-stock-2020-08-03
https://www.nasdaq.com/press-release/avinger-reports-second-quarter-2020-financial-results-2020-07-30
https://www.nasdaq.com/press-release/avinger-to-announce-second-quarter-2020-results-on-july-30-2020-2020-07-27
https://www.nasdaq.com/press-release/avinger-announces-exercise-and-closing-of-underwriters-over-allotment-offering-2020-0
https://www.nasdaq.com/press-release/avinger-closes-%245.4-million-underwritten-public-offering-of-common-stock-2020-06-26
https://www.nasdaq.com/press-release/avinger-prices-%245.4-million-underwritten-public-offering-of-common-stock-2020-06-23
https://www.nasdaq.com/press-release/avinger-announces-510k-filing-of-ocelaris-next-generation-image-guided-cto-crossing
https://www.nasdaq.com/press-release/avinger-reports-first-quarter-2020-financial-results-2020-05-13
https://www.nasdaq.com/press-release/avinger-to-announce-first-quarter-2020-results-on-may-13-2020-2020-05-07
https://www.nasdaq.com/press-release/avinger-announces-exercise-and-closing-of-underwriters-over-allotment-offering-2020
https://www.nasdaq.com/press-release/avinger-closes-%243.15-million-equity-offering-2020-04-30
https://www.nasdaq.com/press-release/avinger-prices-%243.15-million-underwritten-public-offering-of-common-stock-2020-04-27
https://www.nasdaq.com/press-release/avinger-reports-preliminary-first-quarter-2020-revenue-results-2020-04-15
https://www.nasdaq.com/press-release/avinger-reports-fourth-quarter-2019-financial-results-2020-03-05
https://www.nasdaq.com/press-release/avinger-to-announce-fourth-quarter-2019-financial-results-on-march-5-2020-2020-02-27
https://www.nasdaq.com/press-release/avinger-announces-publication-of-scan-clinical-study-in-peer-reviewed-journal-2020-02
https://www.nasdaq.com/press-release/avingers-pantheris-featured-in-live-case-transmission-at-linc-2020-2020-02-04
https://www.nasdaq.com/press-release/avinger-closes-%244.5-million-equity-offering-2020-01-31
https://www.nasdaq.com/press-release/avinger-announces-the-passing-of-director-donald-a.-lucas-2020-01-30
https://www.nasdaq.com/press-release/avinger-prices-%244.5-million-underwritten-public-offering-of-common-stock-2020-01-28
https://www.nasdaq.com/press-release/avinger-enrolls-first-patient-in-image-btk-clinical-study-evaluating-safety-and
https://www.nasdaq.com/press-release/avinger-announces-successful-first-procedures-in-europe-with-ocelaris-chronic-total
https://www.nasdaq.com/press-release/avinger-receives-ce-marking-for-ocelaris-a-next-generation-image-guided-cto-crossing
https://www.nasdaq.com/press-release/avinger-appoints-healthcare-veteran-tamara-elias-md-to-board-of-directors-2019-12-16
https://www.nasdaq.com/press-release/avinger-reports-third-quarter-2019-financial-results-2019-11-05
https://www.nasdaq.com/press-release/avinger-to-announce-third-quarter-2019-financial-results-on-november-5-2019-2019-10
https://www.nasdaq.com/press-release/avinger-expands-us-reach-with-seven-new-accounts-in-third-quarter-2019-10-09
https://www.nasdaq.com/press-release/avinger-announces-full-commercial-launch-of-pantheris-sv-2019-09-18
https://www.nasdaq.com/press-release/avinger-to-present-at-ladenburg-thalmann-healthcare-conference-on-september-24-2019
